Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.

Unit of Internal Medicine, Angiology and Atherosclerosis, Department of Clinical and Experimental Medicine, University of Perugia, S. Maria della Misericordia Hospital, Perugia, Italy. glupa@unipg.it

Journal of clinical pharmacy and therapeutics. 2010;(5):613-5

Abstract

This case report presents the clinical history of a patient with elevated lipoprotein(a) and small size isoform, associated with mixed hyperlipaemia, which was probably familial combined hyperlipaemia. After premature myocardial infarction, the subject was treated with fibrates. Niacin was started after recurrence. One year ago, after another episode of acute coronary syndrome, rosuvastatin was added to niacin. The atherogenicity of this lipid disorder, along with the different options for therapy is discussed.

Methodological quality

Publication Type : Case Reports

Metadata